The International Society for Biological Therapy of Cancer 22nd Annual Meeting: Dinner Symposium: Harnessing Immune Responses and Stem Cell Transplantation as a paradigm of Combination Therapy in CancerFriday, November 2, 2007Seaport World Trade Center in Boston, MassachusettsProgram OrganizersWilliam J. Murphy, PhD - University of Nevada School of MedicineRobert J. Soiffer, MD - Dana-Farber Cancer InstituteProgram SummaryThe focus of this dinner symposium is utilizing immunotherapies (cellular as well as molecular targeting) in combination with hematopoietic stem cell transplantation (HSCT) in the treatment of cancer. Faculty discuss potential synergies in efficacy as well as potential toxicities using immunotherapy or molecular targeting in the context of HSCT in cancer and explore potentially novel interactions of immunotherapy taking place in the context of HSCT. Intended AudienceThe target audience for this program incorporates basic and clinical investigators from academic, regulatory, and biopharmaceutical venues. The audience includes, researchers, clinicians, post-doctoral fellows, students, and allied health professionals.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org